Trazodone Hydrochloride Market

Trazodone, a phenylpiperazine?triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Trazodone hydrochloride is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone hydrochloride is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl] propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H)-one hydrochloride. It is a white odorless crystalline powder which is freely soluble in water.
Trazodone Hydrochloride Market covers Trazodone Hydrochloride (API) (CAS Number: 25332-39-2) and Trazodone API (CAS Number: 19794-93-5).
Trazodone Hydrochloride Market contains market size and forecasts of Trazodone Hydrochloride (API) in global, including the following market information:
Global Trazodone Hydrochloride (API) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Trazodone Hydrochloride (API) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Trazodone Hydrochloride (API) companies in 2021 (%)
The global Trazodone Hydrochloride (API) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trazodone Hydrochloride (API) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Trazodone Hydrochloride (API) include Teva, Angelini, Mylan, Fermion and The Piramal Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Trazodone Hydrochloride (API) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trazodone Hydrochloride (API) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Trazodone Hydrochloride (API) Market Segment Percentages, by Type, 2021 (%)
Trazodone Hydrochloride (API)
Others
Global Trazodone Hydrochloride (API) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Trazodone Hydrochloride (API) Market Segment Percentages, by Application, 2021 (%)
Antidepression
Anxiolytic
Hypnotic
Others
Global Trazodone Hydrochloride (API) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Trazodone Hydrochloride (API) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Trazodone Hydrochloride (API) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Trazodone Hydrochloride (API) revenues share in global market, 2021 (%)
Key companies Trazodone Hydrochloride (API) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Trazodone Hydrochloride (API) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Angelini
Mylan
Fermion
The Piramal Group